HiLo was sponsored by Cancer Research U.K.; Dr. Mallick disclosed that he is a consultant for Genzyme Corp., which provided the rhTSH for the study. ESTIMABL was funded by the French Institute National du Cancer; Dr. Catargi did not mention any financial disclosures.
News
Low-Dose Radioiodine as Effective as Higher Doses in Thyroid Remnant Ablation
Publish date: September 13, 2010
View on the News
Evidence Shows Lower Radioiodine Doses Get the Job Done
Despite a 1996 study that clearly showed that 25 mCi of radioiodine was sufficient to accomplish ablation, I have not been able to get my U.S. colleagues to agree to this lower dose. They are worried about it not working and don’t think it applies to their patients. But these robust studies show that it does work, and it will benefit patients by decreasing the total amount of body radiation.
Ernest Mazzaferri, M.D.
Professor emeritus of medicine, Ohio State University, Columbus